Two Sigma Securities’s Novavax NVAX Stock Holding History

Two Sigma Securities’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$97.2K	Sell	10,323 -3,316	-24%	-$29.7K	0.01%	1305
2026 Q1	$111K	Buy	+13,639	New	+$124K	0.01%	1156
2023 Q3	–	Sell	-11,387	Closed	-$84.6K	–	3309
2023 Q2	$84.6K	Buy	+11,387	New	+$89.5K	﹤0.01%	2333
2022 Q3	–	Sell	-10,385	Closed	-$534K	–	2941
2022 Q2	$534K	Sell	10,385 -8,038	-44%	-$416K	0.02%	864
2022 Q1	$1.36M	Buy	18,423 +16,600	+911%	+$1.48M	0.05%	477
2021 Q4	$261K	Buy	+1,823	New	+$313K	0.01%	903
2019 Q2	–	Sell	-2,430	Closed	-$27K	–	2323
2019 Q1	$27K	Buy	+2,430	New	+$76.7K	﹤0.01%	1653
2018 Q3	–	Sell	-950	Closed	-$25K	–	2882
2018 Q2	$25K	Buy	+950	New	+$32.1K	﹤0.01%	2550
2018 Q1	–	Sell	-1,209	Closed	-$30K	–	2868
2017 Q4	$30K	Sell	1,209 -2,404	-67%	-$58.6K	﹤0.01%	1589
2017 Q3	$82K	Buy	3,613 +540	+18%	+$12.1K	0.01%	693
2017 Q2	$71K	Buy	+3,073	New	+$60.3K	0.01%	689
2016 Q4	–	Sell	-18,042	Closed	-$751K	–	871
2016 Q3	$751K	Buy	+18,042	New	+$2.33M	0.26%	91

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Two Sigma Securities's NVAX Position: Q2 2026 in Review

Two Sigma Securities reduced its Novavax (NVAX) stake by 24% in Q2 2026, selling an estimated $29.7K and leaving 10,323 shares worth $97.2K. The position accounts for 0.01% of the portfolio, ranked #1305.

Two Sigma Securities first reported a position in NVAX in Q3 2016 and has held it in 12 quarters since. The position peaked at $1.36M in Q1 2022. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Two Sigma Securities held 10,323 shares of Novavax worth $97.2K as of Q2 2026.
Two Sigma Securities sold 3,316 Novavax shares in Q2 2026, an estimated $29.7K.
Novavax made up 0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1305 holding.
Two Sigma Securities first reported a position in Novavax in Q3 2016 and has held it in 12 quarters since.
Two Sigma Securities's Novavax position peaked at $1.36M in Q1 2022.
266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.